Patent · US Active

Antiviral agent

US9572813B2 · kind B2 · utility

0Cited by
4References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 23, 2015
Grant dateFeb 21, 2017
Priority date
Expiry dateJan 23, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides an integrase inhibitor. The inventors have found the following compound of formula (I) possessing an integrase inhibitory activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.